Skip Nav Destination
Latest in Immuno-oncology
October 03 2023
Immune-related adverse events after immune checkpoint blockade-based therapy are associated with improved survival in advanced sarcomas
Evan Rosenbaum, Kenneth Seier et al.
September 27 2023
September 21 2023
Mir Lim, Maishara Muquith et al.
September 20 2023
Pancreatic Ductal Adenocarcinoma Cells Regulate NLRP3 Activation to Generate a Tolerogenic Microenvironment
Jesus Amo-Aparicio, Adrian Dominguez et al.
September 11 2023
Richard W. Davis, IV, Astero Klampatsa et al.
September 08 2023
Kyle M. Garland, Alexander J. Kwiatkowski et al.
September 05 2023
Single-cell Profiling Uncovers a Muc4-Expressing Metaplastic Gastric Cell Type Sustained by Helicobacter pylori-driven Inflammation
Valerie P. O'Brien, Yuqi Kang et al.
August 23 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer
Vina P. Nguyen, Katie M. Campbell et al.
August 22 2023
Natural Killer Cell Activation by Ubiquitin-specific Protease 6 Mediates Tumor Suppression in Ewing Sarcoma
Kanika Jain, Ian C. Henrich et al.
August 16 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
Sapna Yadavilli, Jeremy D. Waight et al.